Brevicillin® Stick Packs

Brevicillin® Stick Packs

Products

Information

Brevicillin®: an innovative probiotic based on Bifidobacterium breve PRL2020, which is endowed with high resistance to Amoxicillin and Amoxicillin/Clavulanate (intrinsic resistance that cannot be transferred to other bacteria). This product is designed as an adjunct treatment to Amoxicillin and Amoxicillin/Clavulanate, offering potential benefits and prevention of side effects due to the antibiotic therapy.
Finished Products
Dietary supplements
Delivery Formats
Powder
PHARMEXTRACTA S.P.A.3B6PharmExtracta S.p.A has been operating in the pharmaceutical and nutraceutical field for more than 30 years, bringing innovation and effective therapeutic solutions to the market. The utmost advanced knowledge of our R&D team in Phytotherapy, Probiotics and Nutraceuticals together with a constant communication with Health Care Professionals allows us to develop the most innovative solutions available on the market, to satisfy both patients' and clinicians' needs. PharmExtracta S.p.A presents a portfolio of innovative products developed form cutting-edge formulation rationales and obtained through the optimization of raw materials based on latest scientific discoveries. All finished products are validated by clinical studies published in top scientific journals. Continuous research activity, constant dialogue with Health Care Professionals and support to Pharmacist make PharmExtracta S.p.A a company contemporary to the future.

Join the event!

See all the content and easy-to-use features by logging in or registering!